Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q7272714> ?p ?o }
Showing triples 1 to 27 of
27
with 100 triples per page.
- Q7272714 subject Q6870315.
- Q7272714 subject Q7204516.
- Q7272714 subject Q8636858.
- Q7272714 subject Q8971959.
- Q7272714 abstract "Quizartinib (AC220) is a small molecule receptor tyrosine kinase inhibitor that is currently under development by Ambit Biosciences for the treatment of acute myeloid leukaemia. Its molecular target is FLT3, also known as CD135 which is a proto-oncogene.Flt3 mutations are among the most common mutations in acute myeloid leukaemia due to internal tandem duplication of Flt3. The presence of this mutation is a marker of adverse outcome.".
- Q7272714 iupacName "1-(5-(tert-Butyl)isoxazol-3-yl)-3-(4-(7-(2-morpholinoethoxy)benzo[d]imidazo[2,1-b]thiazol-2-yl)phenyl)urea".
- Q7272714 thumbnail Quizartinib.svg?width=300.
- Q7272714 wikiPageWikiLink Q14912399.
- Q7272714 wikiPageWikiLink Q16827821.
- Q7272714 wikiPageWikiLink Q207609.
- Q7272714 wikiPageWikiLink Q20969938.
- Q7272714 wikiPageWikiLink Q264118.
- Q7272714 wikiPageWikiLink Q420511.
- Q7272714 wikiPageWikiLink Q6870315.
- Q7272714 wikiPageWikiLink Q7202242.
- Q7272714 wikiPageWikiLink Q7204516.
- Q7272714 wikiPageWikiLink Q8636858.
- Q7272714 wikiPageWikiLink Q8971959.
- Q7272714 iupacname "1".
- Q7272714 type ChemicalCompound.
- Q7272714 type ChemicalSubstance.
- Q7272714 type ChemicalObject.
- Q7272714 type Thing.
- Q7272714 type Q11173.
- Q7272714 comment "Quizartinib (AC220) is a small molecule receptor tyrosine kinase inhibitor that is currently under development by Ambit Biosciences for the treatment of acute myeloid leukaemia. Its molecular target is FLT3, also known as CD135 which is a proto-oncogene.Flt3 mutations are among the most common mutations in acute myeloid leukaemia due to internal tandem duplication of Flt3. The presence of this mutation is a marker of adverse outcome.".
- Q7272714 label "Quizartinib".
- Q7272714 depiction Quizartinib.svg.